Ask AI

Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists

Gain expert insights into the latest evidence and guidelines on anti-CD38–based treatments for high-risk smoldering or newly diagnosed multiple myeloma to individualize patient care through certified text modules with accompanying downloadable slides, a ClinicalThought commentary, and a podcast.

Share

Program Content

Activities

AntiCD38 for Smoldering and NDMM
Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 13, 2026

AntiCD38 Tx for Smoldering and NDMM
Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists #2 
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2026

Advances in SMM and NDMM
Advances in Smoldering and Transplant-Eligible Newly Diagnosed Multiple Myeloma: Risk Stratification, MRD-Guided Therapy, and Emerging Treatment Strategies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Transplant Ineligible NDMM
Frontline Management of Transplant-Ineligible Multiple Myeloma: Optimizing Therapy, Supportive Care, and Patient Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Activities

Advances in Smoldering and NDMM
Advances in Smoldering and Transplant-Eligible Newly Diagnosed Multiple Myeloma: Risk Stratification, MRD-Guided Therapy, and Emerging Treatment Strategies
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Expires: January 30, 2027

Frontline Management of Transplant Ineligible MM
Frontline Management of Transplant-Ineligible Multiple Myeloma: Optimizing Therapy, Supportive Care, and Patient Outcomes
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Expires: January 30, 2027

Activities

Individualizing Treatment Strategies in MM
Individualizing Treatment Strategies in Multiple Myeloma: From Risk Assessment to Supportive Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC.

Supporters

Supported by educational grants from Johnson & Johnson and Sanofi Genzyme.

Johnson & Johnson

Sanofi Genzyme